mani
trial
underway
inform
decisionmak
potenti
effect
treatment
provid
suffici
inform
involv
decisionmak
clinician
public
health
author
drug
regulatori
agenc
multipl
endpoint
must
consid
challeng
gener
detail
high
qualiti
evid
data
ensur
fast
avail
evalu
result
review
intervent
trial
remdesivir
lopinavirritonavir
hydroxychloroquin
regist
nation
librari
medicin
nlm
nation
institut
health
nih
summar
endpoint
use
assess
treatment
effect
propos
multist
model
harmon
heterogen
endpoint
differ
length
followup
within
trial
current
march
regist
intervent
trial
investig
potenti
benefit
remdesivir
lopinavirritonavir
hydroxychloroquin
endpoint
highli
heterogen
followup
primari
endpoint
rang
four
day
detail
precis
defin
endpoint
propos
global
network
remapcap
special
communityacquir
pneumonia
sevencategori
endpoint
account
major
clinic
event
inform
decisionmak
moreov
core
outcom
measur
effect
trial
comet
initi
current
work
core
outcom
set
propos
multist
model
accommod
analysi
recommend
endpoint
model
allow
detail
investig
treatment
effect
variou
endpoint
cours
time
therebi
harmon
differ
endpoint
length
followup
multist
model
analysi
power
tool
studi
clinic
heterogen
endpoint
mortal
discharg
well
endpoint
influenc
hospit
capac
durat
hospit
ventil
simultan
time
propos
model
extract
inform
avail
data
harmon
endpoint
within
trial
step
toward
faster
decis
make
ongo
clinic
trial
especi
sever
case
accommod
primari
analysi
stack
probabl
plot
major
event
mechan
ventil
discharg
aliv
death
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
evid
effect
treatment
defeat
need
fast
number
regist
random
trial
studi
promis
antivir
drug
rise
steadili
ensur
time
avail
evalu
result
essenti
studi
compar
time
manifold
way
treatment
may
benefici
effect
need
assess
suffici
inform
decis
maker
must
provid
thu
number
differ
endpoint
major
interest
comprehens
judgement
possibl
treatment
effect
variou
endpoint
present
simultan
core
outcom
measur
effect
trial
comet
initi
current
work
core
outcom
set
co
random
trial
manuscript
propos
multist
model
harmon
multipl
endpoint
allow
detail
understand
treatment
effect
thu
aim
give
recommend
suitabl
endpoint
rather
addit
statist
analysi
provid
major
insight
endpoint
within
exampl
co
comet
first
provid
exemplarili
overview
endpoint
current
use
trial
review
primari
endpoint
clinic
trial
regist
databas
nation
librari
medicin
nlm
nation
institut
health
nih
restrict
review
remdesivir
lopinavirritonavir
hydroxychloroquin
current
among
promis
treatment
option
explain
multist
model
approach
even
though
endpointsreview
restrict
small
number
treatment
propos
multist
method
appli
equal
clinic
trial
review
clinic
trial
provid
overview
primari
endpoint
use
analyz
treatment
effect
includ
random
trial
regist
march
clinic
trial
databas
nlm
nih
primari
purpos
studi
efficaci
remdesivir
lopinavirritonavir
hydroxychloroquin
treatment
diseas
patient
found
trial
met
inclus
criteria
trial
extract
categor
definit
primari
endpoint
moreov
collect
detail
durat
followup
sampl
size
patient
popul
studi
tabl
supplementari
tabl
five
trial
studi
remdesivir
seven
studi
lopinavirritonavir
six
studi
hydroxychloroquin
moreov
three
trial
studi
lopinavirritonavir
hydroxychloroquin
one
studi
remdesivir
hydroxychloroquin
one
involv
three
treatment
main
part
regist
trial
use
recoveri
outcom
primari
endpoint
howev
definit
recoveri
durat
followup
differ
substanti
trial
seven
trial
provid
precis
clinic
definit
primari
endpoint
among
provid
detail
clinic
recoveri
defin
differ
way
followup
trial
recoveri
endpoint
rang
day
trial
followup
day
gener
followup
rang
four
day
trial
followup
day
respect
day
outcom
discharg
clinic
worsen
mortal
viral
load
includ
one
studi
two
primari
endpoint
use
recoveri
endpoint
import
differenti
communityacquir
hospitalacquir
infect
current
case
random
trial
compris
communityacquir
infect
howev
exclud
near
futur
hospitalacquir
random
trial
necessari
definit
recoveri
critic
ill
patient
complex
highli
subject
due
infeas
differenti
symptom
initi
ill
r
blueprint
expert
group
recommend
use
categor
endpoint
rang
full
recoveri
death
exampl
base
recommend
cao
et
al
chose
primari
endpoint
time
clinic
improv
defin
time
random
either
improv
two
point
sevencategori
ordin
scale
discharg
hospit
whichev
came
first
sevencategori
ordin
scale
cao
et
al
consist
follow
categori
hospit
resumpt
normal
activ
hospit
unabl
resum
normal
activ
hospit
requir
supplement
oxygen
hospit
requir
supplement
oxygen
hospit
requir
nasal
highflow
oxygen
therapi
noninvas
mechan
ventil
hospit
requir
ecmo
invas
mechan
ventil
death
six
regist
clinic
trial
use
categor
endpoint
number
categori
vari
six
eight
state
robust
endpoint
ensur
assess
inform
clinician
well
public
health
author
durat
mechan
ventil
hospit
mortal
six
studi
consid
mechan
ventil
primari
endpoint
eight
secondari
endpoint
similarli
hospit
includ
primari
endpoint
seven
studi
six
secondari
endpoint
sixteen
studi
indic
inform
mortal
record
primari
endpoint
secondari
endpoint
studi
unclear
whether
inform
avail
howev
presum
trial
record
inform
heterogen
choic
endpoint
reflect
manifold
potenti
treatment
effect
variou
differ
decis
maker
involv
differ
patient
popul
studi
nonetheless
harmon
differ
endpoint
essenti
step
fasten
decis
make
public
health
author
clinician
time
inform
treatment
effect
lost
oversimplif
propos
harmon
endpoint
also
within
trial
base
inform
major
clinic
event
avail
regist
clinic
trial
name
mechan
ventil
hospit
mortal
categor
endpoint
recommend
r
blueprint
expert
group
ensur
detail
collect
inform
rang
import
event
nonetheless
singl
estim
treatment
effect
albeit
import
summari
benefit
primari
outcom
provid
suffici
inform
timedynam
aspect
treatment
must
understood
detail
make
wellinform
decis
light
emerg
essenti
exploit
full
potenti
avail
data
abl
report
potenti
treatment
effect
multist
methodolog
power
tool
studi
clinic
opposit
endpoint
mortal
discharg
well
endpoint
influenc
hospit
capac
durat
hospit
ventil
simultan
time
durat
mechan
ventil
hospit
well
mortal
robust
endpoint
provid
import
inform
decis
maker
obtain
detail
understand
potenti
treatment
effect
propos
multist
model
shown
figur
clinic
trial
alreadi
start
highli
recommend
provid
stack
probabl
plot
specif
clinic
trial
use
categor
endpoint
recommend
r
blueprint
expert
group
necessari
inform
avail
detail
analysi
plan
novel
trial
urgent
suggest
analyz
avail
data
multist
model
etiolog
treatment
addit
studi
causespecif
cox
regress
possibl
transit
model
differ
durat
hospit
time
spent
mechan
ventil
treatment
control
group
model
transit
probabl
multist
model
model
avoid
common
pitfal
compet
risk
bia
studi
hospit
mortal
immort
time
bia
consid
mechan
ventil
model
allow
detail
inform
treatment
effect
mild
moder
case
shown
figur
analysi
model
figur
principl
model
figur
treatment
effect
one
state
particular
time
point
visual
stack
probabl
plot
quantifi
causespecif
hazard
ratio
possibl
transit
multist
model
explan
multist
model
analysi
softwar
avail
literatur
review
regist
intervent
trial
reveal
high
heterogen
definit
primari
endpoint
studi
use
recoveri
endpoint
primari
analysi
propos
accompani
primari
analysi
multist
methodolog
highlight
literatur
provid
extens
statist
tool
box
suitabl
model
analyz
clinic
trial
ongo
clinic
trial
especi
sever
case
accommod
primari
analysi
stack
probabl
plot
major
event
mechan
ventil
discharg
aliv
death
result
inform
plot
power
tool
harmon
divers
clinic
endpoint
length
followup
therebi
fasten
access
evid
thu
decis
make
addit
treatment
effect
number
potenti
clinic
opposit
endpoint
studi
simultan
time
use
causespecif
cox
regress
estim
sojourn
time
spent
variou
state
moreov
mechan
ventil
hospit
mortal
object
outcom
recoveri
state
sever
influenc
clinic
judgement
may
addit
subject
measur
error
besid
potenti
propos
multist
model
limit
account
patient
triag
possibl
necessit
icu
congest
addit
research
need
avoid
select
bia
aris
special
clinic
situat
final
propos
understood
complement
primari
analysi
rather
suggest
co
trial
provid
way
simultan
evalu
multipl
endpoint
within
co
use
inform
avail
data
conclud
recommend
complement
primari
analysi
stack
probabl
plot
clinic
event
mechan
ventil
discharg
aliv
death
figur
plot
base
simul
data
set
illustr
treatment
respect
control
group
probabl
mechan
ventil
hospit
without
ventil
discharg
aliv
dead
cours
time
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
figur
detail
multist
model
allow
sensit
endpoint
moder
mild
case
color
indic
model
relat
multist
figur
discharg
state
figur
consid
combin
discharg
cure
hospit
normal
ward
hospit
icu
describ
detail
state
non
ventil
figur
label
mild
type
critic
type
variou
state
shall
give
idea
model
account
differ
type
sever
claim
give
precis
clinic
definit
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
tabl
select
column
tabl
summar
result
primari
outcom
review
categori
unclear
column
mortal
mechan
ventil
hospit
indic
suffici
inform
judg
whether
inform
collect
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
